News
1 minute read

MBHB Partner Kevin Noonan Quoted in Law360.com Article Regarding How the EMA's Plan to Share Clinicial Data Could Stifle EU Drug Innovation

Kevin E. Noonan, Ph.D.December 19, 2012

McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a December 19, 2012 edition of Law360.com in an article entitled, “Plan To Share Clinical Data Could Stifle EU Drug Innovation.” The European Medicines Agency’s announcement that it plans to proactively release drug sponsors’ clinical trial data in 2014 has pharmaceutical companies on edge, with experts saying drug companies could avoid seeking approval for their products in European markets, stifling innovation and potentially depriving patients of access to drugs. View the article